RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
85 hedge funds and large institutions have $755M invested in Revance Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 86 → 85 (-1)
Holders
85
Holding in Top 10
1
Calls
$728K
Puts
$700K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$3.52M | |
| 3 | +$2.55M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.47M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.04M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$2.38M | |
| 3 | -$2.36M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.19M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.11M |